Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan-Feb;1(1):3-7.
doi: 10.1016/j.oret.2016.09.006.

The Charles Schepens Lecture: Management Options for Vitreomacular Traction: Use an Individualized Approach

Harry W Flynn Jr  1 , Nidhi Relhan  1
Affiliations

The Charles Schepens Lecture: Management Options for Vitreomacular Traction: Use an Individualized Approach

Harry W Flynn Jr et al. Ophthalmol Retina. 2017 Jan-Feb.

Abstract

Purpose: To present the management options for vitreomacular traction (VMT) and to recommend an individualized approach to treatment selection.

Design: Presented at the American Academy of Ophthalmology Annual Meeting, 2016, Chicago, October 15, 2016 (The Charles Schepens Lecture).

Participants: None.

Methods: Review of published literature and clinical trials.

Main outcome measures: Visual and anatomic outcomes of various treatment options for VMT were reviewed.

Results: The management options for VMT include pars plana vitrectomy, pneumatic vitreolysis, enzymatic vitreolysis, and observation. The surgical management using pars plana vitrectomy offers the most effective approach for VMT, but there are inherent risks and cost issues. Pneumatic vitreolysis is reported to be cost-effective and may be an anatomically successful nonsurgical option for management. Enzymatic vitreolysis with intravitreal ocriplasmin is another nonsurgical option, but both short- and long-term side effects may occur. Observation in selected patients can be associated with stable visual outcomes during long-term follow-up.

Conclusions: The final management decision should be individualized for specific patients depending on the patient's clinical findings, potential risks, probable benefits, and costs of each option.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Dr Charles L. Schepens.
Figure 2
Figure 2
Vitreomacular traction with surface retinal distortion, intraretinal cystic changes, and distortion of the ellipsoid zone on optical coherence tomography.
See this image and copyright information in PMC

References

    1. Palacio AC, Gupta A, Nesmith BL, et al. Vitreomacular adhesion evolution with age in healthy human eyes. Retina. 2016 Jun 15; [Epub ahead of print] - PubMed
    1. Johnson MW. How should we release vitreomacular traction: surgically, pharmacologically, or pneumatically? Am J Ophthalmol. 2013;155:203–205. e1. - PubMed
    1. Duker JS, Kaiser PK, Binder S, et al. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology. 2013;120:2611–2619. - PubMed
    1. Smiddy WE, Michels RG, Glaser BM, et al. Vitrectomy for macular traction caused by incomplete vitreous separation. Arch Ophthalmol. 1988;106:624–628. - PubMed
    1. Sonmez K, Capone A, Jr, Trese MT, et al. Vitreomacular traction syndrome: impact of anatomical configuration on anatomical and visual outcomes. Retina. 2008;28:1207–1214. - PubMed

LinkOut - more resources